InSilixa, Inc.
USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).
The verdict
According to USPTO PatentsView, Insilixa ranks #32,080 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.
- #32,080
- of 49,997 US assignees by volume
- Top 36%
- by Innovation Score (40.3/100)
- 21.1
- avg claims per patent
- -25%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R32080 · US Corporation #32,080 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #32,080/49,997
- PHOTO-FINISH Implant Sciences
- CPC-NARROW C12Q · 8 areas
- INNOV-PAR 40.3/100
- CLAIMS-DENSE 21.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DOWN -25% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Implant Sciences Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Insilixa’s 40.3 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Insilixa
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- InSilixa · this assignee
InSilixa · this assignee
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Insilixa's Innovation Score is 40.3/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Insilixa?
Each dot is one of Insilixa’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Insilixa’s own 21.1 claims/patent is ABOVE the 20.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Insilixa's grants concentrate
InSilixa, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 87.5% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2016. By volume, Insilixa sits between Implant Sciences Corporation and Index Pharmaceuticals AB.
Insilixa's three-year grant acceleration
InSilixa, Inc. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at InSilixa's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Implant Sciences
Implant Sciences Corporation
8 patents
- Implicit
Implicit, LLC
8 patents
- Imprenditore Pty
Imprenditore Pty Ltd.
8 patents
- In2bones
In2Bones, LLC
8 patents
- Inview Technology
InView Technology Corporation
8 patents
- Incodema3d
Incodema3D, LLC
8 patents
- Indeed
Indeed, Inc.
8 patents
- Index Pharmaceuti…
Index Pharmaceuticals AB
8 patents
- Insilixa ◀
InSilixa, Inc.
8 patents
What this shows InSilixa holds 8 patents at rank #32,084, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near InSilixa
By rank, the assignees closest to #32,084 in granted patent volume.
- Implant Sciences Corporation #32,080 · 8 patents
- Implicit, LLC #32,081 · 8 patents
- Imprenditore Pty Ltd. #32,082 · 8 patents
- In2Bones, LLC #32,083 · 8 patents
- InView Technology Corporation #32,085 · 8 patents
- Incodema3D, LLC #32,086 · 8 patents
- Indeed, Inc. #32,087 · 8 patents
- Index Pharmaceuticals AB #32,088 · 8 patents
Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)
Other assignees with the most granted patents in InSilixa's primary technology class.
- The Regents of the University of California 581 in class
- Life Technologies Corporation 546 in class
- Illumina, Inc. 445 in class
- President and Fellows of Harvard College 387 in class
- Immatics Biotechnologies GmbH 286 in class
- 10x Genomics, Inc. 282 in class
- The Board of Trustees of the Leland Stanford Junior University 266 in class
- Pacific Biosciences OF California, Inc. 259 in class
Insilixa's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2017 | 1 | 12.5% |
| 2019 | 2 | 25.0% |
| 2022 | 2 | 25.0% |
| 2023 | 1 | 12.5% |
| 2025partial year | 1 | 12.5% |
Which technologies does InSilixa, Inc. patent most?
Top 8 of 8 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
InSilixa, Inc.'s patent record in context - here's where to go next.
- InSilixa, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 87.5% of its portfolio - see every assignee active in that class. Explore C12Q
- Ranked #32,080 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare InSilixa, Inc. against Implant Sciences Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.